Live feed
Filing
SC 13G/A
SC 13G/A0001753926-21-000622·Fresh Tracks Therapeutics, Inc.
Schedule 13G ownership disclosure
Brickell Biotech, Inc.
Security class unavailable · CUSIP: 10802T105
Event date: 2021-10-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,286,066
- Percent of class
- 6.3300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-21-000622
- Form type
- SC 13G/A
- Filer
- Fresh Tracks Therapeutics, Inc.
- CIK
- CIK 819050
- Filed
- Nov 03, 2021
- Reporting period
- Oct 28, 2021
- Description
- Schedule 13G beneficial ownership